BioSpace News Archive

Total ankle replacement or total ankle arthroplasty is recommended if a patient suffers from ankle arthritis. It is a surgical procedure, in which the ankle of a patient is replaced so that she or he can experience improved mobility and decreased pain during the day to day activities.

Sequana Medical NV, an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, announces positive interim results from six patients in SAHARA DESERT, the safety and feasibility study of alfapump DSR in heart failure patients with persistent congestion.

Hansa Biopharma AB and Medison Pharma announce a multiregional agreement for Medison to commercialize Hansa’s desensitization treatment for kidney transplants in Central Eastern Europe and Israel.

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced an update to preclinical data on bioRxiv1, a preprint server, demonstrating that sotrovimab, an investigational monoclonal antibody, retains in vitro activity against the full known Omicron spike protein, the new SARS-CoV-2 variant.

Vir Biotechnology, Inc. announced that Management will host a conference call at 8:30 am ET, Tuesday, December 7, 2021, to discuss new data that demonstrates sotrovimab retains activity against the full combination of mutations in the spike protein of the Omicron SARS-CoV-2 variant.

Galderma, the world’s largest independent dermatology company, announced that Maria Teresa “Tessa” Hilado will join its Advisory Committee, effective January 1, 2022.

Sino Biological, Inc. announced that it has launched a panel of research reagents for the newly identified Omicron variant of the SARS-COV-2 virus, which quickly raised concerns around the world because of the high number of mutations it carries, especially the 30-plus mutations on the Spike protein.

Metrion Biosciences Limited, the specialist ion channel contract research and drug discovery company, announced it has expanded its capabilities and expertise through the addition of automated low volume liquid handling capability and 384-well electrophysiology and fluorescence-based high throughput screening assay systems.

CB Scientific. Inc. announced Shenzhen Pump Medical System Co., Ltd. has issued a formal Letter of Intent to manufacture the Company’s products targeting key Southeast Asia markets including China, Malaysia, Thailand, Indonesia, and Singapore.

Alvotech Holdings S.A., a leading global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, and Oaktree Acquisition Corp. II, a special purpose acquisition company sponsored by an affiliate of Oaktree Capital Management, L.P., announced that they have entered into a definitive merger agreement.